Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 118309
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118309
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118309
| Indications for kidney replacement therapy | |
| Absolute indications | Refractory hyperkalemia (K+ > 6.5 mmol/L, rapidly increasing or associated with cardiac arrhythmias) |
| Refractory pulmonary edema (diuretic resistant) | |
| Refractory metabolic acidosis (pH < 7.2) | |
| Blood urea nitrogen concentration of > 40.0 mmol/L | |
| Uremia with signs and symptoms (e.g., pericarditis, encephalopathy, bleeding) | |
| Refractory fluid overload with organ dysfunction | |
| Concomitant drug/toxin intoxication that is dialysable | |
| Relative indications | Severe non-renal organ dysfunction from AKI/fluid overload |
| Progressive/persistent AKI (serum creatinine > 3 times baseline and/or profound oliguria) | |
| Worsening trajectory of critical illness |
- Citation: Wong FHA, See KC. Critical care considerations in rhabdomyolysis-associated acute kidney injury and kidney replacement therapy. World J Nephrol 2026; 15(2): 118309
- URL: https://www.wjgnet.com/2220-6124/full/v15/i2/118309.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i2.118309